Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Innovation Medicine is Scopus-indexed (Q2, CiteScore 4.5), DOAJ. Published by Innovation Press.
Checked against the index lists dated .
ISSN 2959-8745Verify ISSN ↗
Publisher: Innovation Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Public Health, Environmental and Occupational Health | 208 / 725 | 71st | Q2 |
| Cardiology and Cardiovascular Medicine | 123 / 409 | 70th | Q2 |
| Epidemiology | 59 / 173 | 66th | Q2 |
| Oncology | 186 / 428 | 56th | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q2, CiteScore 4.5.
Innovation Medicine is Q2 in Public Health, Environmental and Occupational Health (rank 208 of 725), Q2 in Cardiology and Cardiovascular Medicine (rank 123 of 409) and Q2 in Epidemiology (rank 59 of 173), by CiteScore 2025. It is ranked in 4 subject areas in all.
Innovation Medicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 4.5, quartile Q2, 71st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.848, quartile Q2, with an H-index of 11.
Innovation Medicine is published by Innovation Press. Its ISSN is 2959-8745.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Innovation Medicine has an h-index of 16 and a 2-year mean of 2.92 citations per paper (OpenAlex). Its Scopus CiteScore is 4.5, quartile Q2. On 2-year citations it ranks #140 of 710 Scopus journals in Public Health, Environmental and Occupational Health.
Innovation Medicine published 72 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 72 research articles (2025–2026), authors are most often from China (79.9%), United States (6%) and United Kingdom (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.